gsk
GSK Finds Potential Weapon Against 'Superbugs'
Drug-resistant bacteria has become a pressing public health problem, exacting a rising human and financial toll. GlaxoSmithKline announced that it has found a compound that could help attack such 'superbugs'.
FDA Panel Votes to Keep Avandia on Market
GlaxoSmithKline diabetes drug Avandia has been found to have increased heart attack risk compared to similar medication. But a majority of the Food and Drug Administration's panel of outside experts have voted to keep the drug on the market -- though new restrictions are likely.
